Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) had an opportunity to acquire US pharmaceuticals company Perrigo Company (NYSE:PRGO; TASE:PRGO) a few months ago, and said it was not interested, sources inform “Globes.” Perrigo hired bankers last summer to assess the possibility of its sale via a merger with a large pharmaceuticals company, and those bankers approached Teva and proposed that it acquire Perrigo…. [READ MORE]
Published by Globes [online], Israel business news – www.globes-online.com
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at email@example.com.